Exit
Petit déjeuner exécutif avec les industries des sciences de la vie et du dispositif médical

Petit déjeuner exécutif avec les industries des sciences de la vie et du dispositif médical

Compliance et transparence dans l’activité commerciale : automatisation du contrôle de la gestion Le 1er mars 2017 a eu lieu à Madrid le deuxième évènement organisé par BMI SYSTEM et Deloitte. Pour rappel, le premier évènement s’est déroulé à Barcelone, le 30 novembre 2016. L’objectif de ce second évènement était de présenter le partenariat entre les […]

Read more
Article FENIN : Le secteur du dispositif médical suit les traces de l'industrie pharmaceutique

The Medical Device Sector Follows in the Footsteps of the Pharmaceutical Industry

The evolution of the regulatory context in the healthcare industry has been continuous, especially over the last 3 years. An example of this can be seen in the approval of FENIN’s ethical code (the Spanish Federation of Medical Device Companies), on December 20th 2016. FENIN has now integrated the MEDTECH requirements (European Association of Medical […]

Read more
Article FENIN : Le secteur du dispositif médical suit les traces de l'industrie pharmaceutique

Le secteur du dispositif médical suit les traces de l’industrie pharmaceutique

L’évolution du contexte réglementaire dans l’industrie de la santé a été constante, surtout au cours des trois dernières années. On peut le voir par l’approbation du Code d’éthique FENIN (Fédération espagnole des entreprises du dispositif médical), le 20 décembre 2016. La FENIN intègre désormais les exigences du MEDTECH (Association européenne du dispositif médical) dans sa […]

Read more
Compliance in Saudi Arabia

Compliance in Saudi Arabia – Middle East

As the pharmaceutical industry continues to impact the lives of patients all over the world, it remains one of the most crucial industries that face public scrutiny and pressure to adhere to the best transparency practices possible. To ensure ethical practice in the promotion of new therapies to healthcare professionals (HCPs), governments in the US […]

Read more
A French bill for the transparency of economic life

A French bill for the transparency of economic life

New measures to prevent the risk of corruption and conflict of interest in France In July 2015 the French Minister of Finance and Public Accounts Michel Sapin, presented a communication on government action in favor of transparency and probity for economic and financial players. Transparency and probity for economic and financial players are economic and […]

Read more

BMI SYSTEM Newsletter – January 2016

The BMI SYSTEM Newsletter of January 2016 has just been published. Click below to take a look: To subscribe:

Read more
Working together for patients

EFPIA: Working together for patients

In 2015, the EFPIA, European Federation of Pharmaceutical Industries and Associations, launched a public information campaign to raise awareness of new financial disclosure rules and to “boost pharmaceutical industry preparedness with complying to new disclosure rules [1]”. The campaign includes several communications materials: Online videos explaining the Code and testimonials from healthcare professionals Information leaflets […]

Read more
suscribe to BMI SYSTEM newsletter

BMI SYSTEM Newsletter – December 2015

The BMI SYSTEM Newsletter of December 2015 has just been published. To take a look at it click below : To suscribe :

Read more
Why do the pharmaceutical industry & healthcare professionals work together?

Why do the pharmaceutical industry & healthcare professionals work together?

Read more

Can the UK learn from the Sunshine Act?

At the end of last month, a milestone was reached in the US in the drive to make payments from pharmaceutical and medical device companies to doctors and teaching hospitals more transparent. The Physician Payments Sunshine Act, called for all transfers of value to doctors to be made publicly available by the 30th of September […]

Read more
Close
Go top